Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 9/2010

01-09-2010 | Gynecologic Oncology

Risk of Postoperative Pelvic Abscess in Major Gynecologic Oncology Surgery: One-Year Single-Institution Experience

Authors: Anna Fagotti, MD, Barbara Costantini, MD, Francesco Fanfani, MD, Giuseppe Vizzielli, MD, Cristiano Rossitto, MD, Antonella Lecca, MD, Giovanni Scambia, MD

Published in: Annals of Surgical Oncology | Issue 9/2010

Login to get access

Abstract

Purpose

This study was undertaken to evaluate risk factors for the occurrence of postoperative abscesses in a large single-institution series of gynecologic cancer patients undergoing major surgery.

Materials and Methods

Patients admitted to the Division of Gynecologic Oncology, Catholic University of Sacred Hearth, Rome, Italy, between January 2008 and February 2009, were retrospectively analyzed. The occurrence of pelvic abscesses was identified by sign and symptoms and confirmed with radiological and microbiological examinations.

Results

A total of 360 patients were analyzed for the study. Exenteration and use of fibrillar absorbable hemostat were significantly associated with the presence of postoperative abscesses (P < .0001) by multiple regression analysis, whereas operative time, type of surgery, lymphadenectomy, or other associated surgical procedures failed to result statistically relevant.

Conclusions

The use of fibrillar oxidized regenerated cellulose as hemostatic agent may represent a risk factor for postoperative abscesses, especially when used during pelvic exenteration.
Literature
1.
Kehoe S. Treatments for gynecological cancers. Best Pract Res Clin Obstet Gynaecol. 2006;20:985–1000.CrossRefPubMed
2.
Chan KK, Naik R. Advances in surgical treatment of cervical cancer. Womens Health (Lond Engl). 2008;4:245–56.
3.
Benedetti-Panici P, Maneschi F, Cutillo G, Greggi S, Salerno MG, Amoroso M, et al. G. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results. Cancer. 1996;78:2359–65.CrossRefPubMed
4.
Van der Burg ME, Vergote I. Gynecological Cancer Group of the EORTC. The role of interval debulking surgery in ovarian cancer. Curr Oncol Rep. 2003;5:473–81.CrossRefPubMed
5.
Bosze P, Meszaros I, Palfalvi L, Ungar L. Perioperative complications of 116 radical hysterectomies and pelvic node dissections. Eur J Surg Oncol. 1993;19:605–8.PubMed
6.
Zorlu CG, Aydoğdu T, Ergün Y, Kuşçu E, Cobanoğlu O, Koçak S. Complications of radical hysterectomy: clinical experience of 115 early stage cervical cancers. Gynecol Obstet Invest. 1998;45:137–9.CrossRefPubMed
7.
Gadducci A, Cosio S, Spirito N, Genazzani AR. The perioperative management of patients with gynaecological cancer undergoing major surgery: a debated clinical challenge. Crit Rev Oncol Hematol. 2010;73:126–40.CrossRefPubMed
8.
Dicker RC, Greenspan JR, Strauss LT, Cowart MR, Scally MJ, Peterson HB, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol. 1982;144:841–84.PubMed
9.
Fanning J, Neuhoff RA, Brewer JE, Castaneda T, Marcotte MP, Jacobson RL. Frequency and yield of postoperative fever evaluation. Infect Dis Obstet Gynecol. 1998;6:252–5.CrossRefPubMed
10.
Tanos V, Rojansky N. Prophylactic antibiotics in abdominal hysterectomy. J Am Coll Surg. 1994;179:593–600.PubMed
11.
Ailawadi M. and Del Priore G. A comparison of thromboembolic prophylaxis in gynecologic oncology patients. Int J Gynecol Cancer. 2001;11:354–8.CrossRefPubMed
12.
ACOG Committee on Practice Bulletins. Antibiotic prophylaxis for gynecologic procedures. ACOG Practice Bulletin No. 74. Obstet Gynecol. 2006;108:225–34.
13.
Oliveira L, Wexner SD, Daniel N, DeMarta D, Weiss EG, Nogueras JJ, et al. Mechanical bowel preparation for elective colorectal surgery. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions. Dis Colon Rectum. 1997;40:585–91.CrossRefPubMed
14.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMed
15.
Cox DR. Analysis of binary data. London: Methven; 1970.
16.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–78.CrossRefPubMed
17.
Leitao MM Jr, Natenzon A, Abu-Rustum NR, Chi DS, Sonoda Y, Levine DA, et al. Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers. Gynecol Oncol. 2009;115:204–8.CrossRefPubMed
18.
Mazeh H, Samet Y, Abu-Wasel B, Beglaibter N, Grinbaum R, Cohen T, et al. Application of a novel severity grading system for surgical complications after colorectal resection. J Am Coll Surg. 2009;208:355–61.CrossRefPubMed
19.
Bochner BH, Mc Creath WA, Aubey JJ. Use of ureteroileocecalappendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation. Gynecol Oncol. 2004;94:140–6.CrossRefPubMed
20.
Caceres A, Mourton SM, Bochner BH, Gerst SR, Liu L, Alektiar KM, et al. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. Int J Gynecol Cancer. 2008;18:1139–44.CrossRefPubMed
21.
Spangler D, Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect (Larchmt). 2003;4:255–62.CrossRef
22.
Scher KS, Coil JA Jr. Effects of oxidized cellulose and microfibrillar collagen on infection, Surgery. 1982;91:301–4.PubMed
23.
Vytrasova J, Tylsova A, Brozkova I, Cervenka L, Pejchalova M, Havelka P. Antimicrobial effect of oxidized cellulose salts. J Indian Microbiol Biotechnol. 2008;35:1247–52.CrossRefPubMed
24.
Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;13:S89–96.CrossRefPubMed
25.
Kothbauer KF, Jallo GI, Siffert J, Jimenez E, Allen JC, Epstein FJ. Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases. J Neurosurg. 2001;95:503–6.CrossRefPubMed
26.
Gao HW, Lin CK, Yu CP, Yu MS, Chen A. Oxidized cellulose (Surgicel) granuloma mimicking a primary ovarian tumor. Int J Gynecol Pathol. 2002;21:422–3.CrossRefPubMed
27.
Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver WC Jr. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery. 2008;63:369–72.CrossRefPubMed
28.
Toglia MR, Pearlman MD. Pelvic fluid collections following hysterectomy and their relation to febrile morbidity. Obstet Gynecol. 1994;83:766–70.PubMed
29.
Bjorenson JE, Grove HF, List MG Sr, Haasch GC, Austin BP. Effects of hemostatic agents on the pH of body fluids. J Endod. 1986;12:289–92.CrossRefPubMed
30.
McRitchie DI, Girotti MJ, Glynn MF, Goldberg JM, Rotstein OD. Effect of systemic fibrinogen depletion on intra-abdominal abscess formation. J Lab Clin Med. 1991;118:48–55.PubMed
31.
Rotstein OD. Role of fibrin deposition in the pathogenesis of intraabdominal infection. Eur J Clin Microbiol Infect Dis. 1992;11:1064–8.CrossRefPubMed
32.
Reijnen MM, Bleichrodt RP, van Goor H. Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg. 2003;90:533–41.CrossRefPubMed
33.
Seyednejad H, Imani M, Jamieson T, Seifalian AM. Topical haemostatic agents. Br J Surg. 2008;95:1197–225.CrossRefPubMed
34.
Querleu D, Morrow CP. Classification of radical hysterectomy. Gynecol Oncol. 2009;115:314–5; author reply 315–6.
Metadata
Title
Risk of Postoperative Pelvic Abscess in Major Gynecologic Oncology Surgery: One-Year Single-Institution Experience
Authors
Anna Fagotti, MD
Barbara Costantini, MD
Francesco Fanfani, MD
Giuseppe Vizzielli, MD
Cristiano Rossitto, MD
Antonella Lecca, MD
Giovanni Scambia, MD
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 9/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1059-3

Other articles of this Issue 9/2010

Annals of Surgical Oncology 9/2010 Go to the issue

Breast Oncology

Metastasectomy and Surgical Resection of the Primary Tumor in Patients With Stage IV Breast Cancer

Healthcare Policy and Outcomes

Annals of Surgical Oncology: The Global Journal for Surgeons Treating Patients with Cancer

Breast Oncology

Ki-67 and Bcl-2 Antigen Expression in Adenomatous Colorectal Polyps from Women with Breast Cancer

Melanomas

Utility of Lymph Node Assessment for Atypical Spitzoid Melanocytic Neoplasms

Hepatobiliary Tumors

Improved Results of a Surgical Resection for the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation

Healthcare Policy and Outcomes

Predicting Adverse Outcomes After Complex Cancer Surgery